Skip to content Skip to navigation

TransGenex Nanobiotech, Inc.

TransGenex Nanobiotech, Inc.

TGN’s business strategy involves both short- and long-term objectives that will generate revenue in the present and facilitate future R & D. TGN continues to generate revenue from the sales of custom nanoparticles and Nanogene™ reagents and Federal and State grant-funding mechanisms for small businesses to support R & D. TGN plans to develop and market diagnostic reagents/kits for the detection of viral infections, including AIDS, and the early detection of cancers. It is seeking investors and/or strategic partners to advance product development, including the introduction of several diagnostic tool kits to the market in 2008 and beyond.

TransGenex Nanobiotech, Inc.
13719 N. Nebraska Ave.
Suite 108
Tampa, FL
33613
USA
view on map

http://transgenex.com/
transgenex@transgenex.com
(813) 975-9649

Type: 
Industry